(EHC) Encompass Health - Ratings and Ratios

Encompass Health Corporation is a leading provider of post-acute healthcare services in the United States and Puerto Rico, operating a network of inpatient rehabilitation hospitals that offer a range of medical, nursing, therapy, and ancillary services to patients with complex medical conditions, such as strokes, hip fractures, and neurological disorders.

The companys business model is centered around providing specialized rehabilitative treatment to patients through various payment channels, including Medicare, managed care plans, private insurers, and state governments. With a strong presence in the US healthcare market, Encompass Health Corporation has established itself as a major player in the post-acute care sector, leveraging its expertise and resources to deliver high-quality patient care.

From a technical analysis perspective, Encompass Health Corps stock (EHC) is currently trading at $121.29, above its 20-day SMA of $119.67 and 50-day SMA of $111.11, indicating a bullish trend. The stocks ATR of 2.39 (1.97%) suggests moderate volatility, while its 52-week high and low of $121.73 and $83.53, respectively, indicate a significant price recovery over the past year.

Combining technical and fundamental analysis, we can forecast that Encompass Health Corps stock is likely to continue its upward trend, driven by the companys strong financial performance and growth prospects in the post-acute care market. With a market capitalization of $12.186 billion and a forward P/E ratio of 24.75, the stock appears reasonably valued. Additionally, the companys return on equity (RoE) of 24.66% suggests a high level of profitability. Based on these factors, we can expect EHCs stock price to potentially reach $130-$140 in the near term, representing a 7-15% upside from current levels.